Portable probes hunt down cancer cells during surgery

June 8, 2016 by Laure-Anne Pessina

Light, wireless probes the size of a large pen have been developed to identify cancer cells and suspicious lymph nodes during surgery. The probes, which EPFL helped develop, are now being tested by surgeons at the University Hospital of Lausanne (CHUV) and across Europe.

When surgeons remove a malignant tumor, they have to be sure to get all the . Just as crucial, they have to determine whether the tumor has already sent micrometastases into the neighboring on the way to the rest of the body.

EPFL, in partnership with Forimtech and the CHUV, developed two compact, light and wireless probes that help doctors with both of these tasks. The Gamma probe improves on similar devices already in use in radioguided surgery, while the Beta probe is a totally new type of device able to detect extremely small bits of cancerous tissue.

The two probes, measuring 20 centimeters long and weighing barely 100 grams, are easy to work with and to insert into the surgical wound. The probes guide the surgeon with auditory signals similar to those of a Geiger counter, accurately locating what the human eye often cannot see.

Hunting down malignant cells

The Beta probe is based on a new concept of particle detection. It identifies the presence of even minute quantities of cancer cells from the main tumor. After removing the tumor, the surgeon will use the probe to see if there is any residual cancer tissue.

The probe works by searching for positrons, which are given off by a tracer substance that, once administered to the patient, attaches itself to cancer cells. Positrons can only travel through one millimeter of tissue. When they are found, cancer cells cannot be far away.

The Beta probe reduces the risk of complications and helps prevent the disease from spreading further. Because it pinpoints unhealthy cells, surgeons are able to preserve as much healthy tissue as possible. The device is still in the clinical test phase. A three-year effectiveness study on 60 patients is under way at the CHUV.

Looking for sentinel lymph nodes and metastases

The Gamma probe represents an improvement on an existing technology. It doesn't detect cancer cells directly, but it finds the sentinel lymph node near the main tumor. This is the lymph node that cancer cells first reach before spreading to the rest of the body. It is removed and examined by doctors to determine the stage of the disease and identify the most appropriate treatment.

"With the Gamma probe, we can remove just the sentinel lymph node. And if it turns out to be free of cancer cells, that means the tumor hasn't spread," said Maurice Matter, a surgeon at the CHUV.

The probe that EPFL helped develop is lighter, more accurate and easier to use than competing devices, and it finds the sentinel lymph node more quickly.

Miniaturizing the electronics

In the case of both probes, the role of EPFL's researchers was to design the device and miniaturize the electronics. "The system has to be solid enough to withstand sterilization," said Edoardo Charbon, the director of the Advanced Quantum Architecture Lab (AQUA). "The has a little window at one end that picks up the gamma rays or positrons given off by the substance injected into the patient. A scintillator converts the energy of the rays into photons, which are then detected by a highly sensitive sensor."

The probes, which were given the CE mark in March 2015, have already been used in around 30 operations at the CHUV. Starting this year, testing will be rolled out to hospitals across Europe.

Explore further: Advances in fluorescent probe technology could allow real-time visualization of cancer progression during surgery

Related Stories

Advances in fluorescent probe technology could allow real-time visualization of cancer progression during surgery

June 4, 2014
In order to determine the best treatment for patients affected by cancer, it is crucial for physicians to identify how the disease is spreading via lymph nodes in the body—a process known as metastasis. Progression of the ...

Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy

December 5, 2012
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of ...

Researchers develop 'killer cells' to destroy cancer in lymph nodes

November 12, 2015
Cornell biomedical engineers have developed specialized white blood cells - dubbed "super natural killer cells" - that seek out cancer cells in lymph nodes with only one purpose: destroy them. This breakthrough halts the ...

Which breast cancer patients need lymph nodes removed? Ultrasound narrows it down

February 2, 2015
Which breast cancer patients need to have underarm lymph nodes removed? Mayo Clinic-led research is narrowing it down. A new study finds that not all women with lymph node-positive breast cancer treated with chemotherapy ...

Long-term study confirms success of method for detecting spread of deadly skin cancer

March 4, 2014
Research at UCLA on a technique for detecting the earliest spread of melanoma, the deadliest form of skin cancer, has confirmed that the procedure significantly prolongs patients' survival rates compared with traditional ...

Recommended for you

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.